Ciclesonide Market| Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• CICLESONIDE MARKET ANALYSIS
• Ciclesonide Market, by Indication (Asthma and
  Allergic Rhinitis), by Dosage Form (Aerosol and
  Nasal Spray), and by Region (North America, Latin
  America, Europe, Asia Pacific, Middle East, and
  Africa) - Size, Share, Outlook, and Opportunity
  Analysis, 2018-2026
• The global ciclesonide market size is estimated
  to be valued at US 565.4 million in 2018 and is
  expected to witness a CAGR of 1.9 over the
  forecast period (20182026).

3

• Ciclesonide, are used to prevent the difficulty
  in breathing, chest tightness, wheezing, and
  coughing caused by asthma in adults and children
  12 years of age and older. It works as a being
  class of corticosteroid medication to decrease
  swelling and irritation in the airways allowing
  easy breathing. Ciclesonide comes in aerosol and
  nasal spray, and usually need to inhale twice a
  day. It help to prevent the asthma attack
  including sudden episodes of shortness of breath,
  wheezing, and coughing.
• A study findings published by the Asthma and
  Allergy Foundation of America (AAFA) in October
  2015 revealed that, air pollution can worsen
  existing asthma symptoms. According to same
  source, a study of young campers with moderate to
  severe asthma reported that, they were 40 more
  likely to have acute asthma episodes on high
  pollution summer days as compared to days with
  average pollution levels. Pollution is common
  cause of asthma in people, and people face
  various kinds of pollutants generated through
  traffic fumes, wood smoke, dust, smoke, and
  diesel fumes, which make airways inflamed and
  swollen, triggering asthma symptoms.

4

• Global Ciclesonide Market Share Analysis (US
  Mn), by Region, 2018

5

• High Prevalence of Allergy Rhinitis and Asthma is
  Expected to Augment the Market Growth
• Ciclesonide is widely used in the treatment of
  asthma and allergy rhinitis. Allergy rhinitis and
  asthma are very common conditions and prevalence
  of these two disease is very high in countries
  such as the U.S., U.K., China, and India. Hence,
  high prevalence of allergy rhinitis is expected
  to drastically increase demand for ciclesonide
  and drive its market growth over forecast period.
  According to the Global Asthma Report published
  in 2018, an asthma kills around 1,000 people
  every day and affects as many as 339 million
  people worldwide. Prevalence of asthma is rising
  and people in low- and middle-income countries
  suffer the most.
• According to the data published by National
  Center for Biotechnology Information (NCBI), in
  January 2018, prevalence of allergy rhinitis in
  Asia, Europe, the Americas, and Africa region was
  around 1525 among children and adolescents, as
  well as young adults.

6
Global Ciclesonide Market Share (), By Dosage
Form 2018 2026

7

• Ciclesonide is novel inhaled corticosteroids,
  majorly preferred by asthma and COPD patients, to
  relive the underlying symptoms. This generates
  great opportunity for key players in the market
  to launch ciclesonide-based products.
• Key players have opportunities to penetrate in
  the untapped potential markets where prevalence
  of allergy rhinitis and asthma is very high and
  the accessibility of ciclesonide is less due to
  the low presence of market players. According to
  Global Asthma Report published in 2018, in some
  countries of Asia Pacific such as China, India,
  Indonesia, Malaysia, and Thailand, burden of
  asthma is substantial, however, asthma remains
  underdiagnosed and undertreated. According to the
  same source, many asthma patients are not using
  inhaled corticosteroids, as these medicines are
  either inaccessible or unaffordable. Therefore,
  key players could focus on these markets and
  fulfill the unmet need of these potential regions
  to generate high market revenue.
• However, presence of alternative mediation and
  possible risk of pneumonia and other respiratory
  infections among asthma children who use Safety
  of inhaled corticosteroids (ICS), may hinder
  growth of the ciclesonide market.

8

• With the expiry of branded ciclesonide products
  such as OMNARIS Nasal Spray and ALVESCO it is
  expected that generic manufacturers will enter
  the market. Launch of generic versions of
  ciclesonide will increase competition and will
  restrain growth of the market in terms of revenue
  as generic products are available in less price.
  For instance, according to the data published in
  Sepracor Inc. annual report, OMNARIS Nasal Spray
  and ALVESCO HFA lost their patent in October
  2017. Thus, patent lose can affect and hinder the
  market growth in terms of revenue.
• North America is expected to hold a dominate
  position in global ciclesonide market in 2017,
  owing to high prevalence of allergy rhinitis and
  asthma conditions and increasing drug launches in
  this region. For instance, in 2012, Sunovion
  Pharmaceuticals Inc. received the U.S. Food and
  Drug Administration (FDA) approval for its
  Zetonna (ciclesonide) nasal aerosol for the
  treatment of allergic rhinitis and launched it in
  the U.S. market. Furthermore, according to the
  data published by American Academy of Allergy
  Asthma Immunology, in 2016 around 8.3 of
  children in the U.S. suffered from asthma.
• Some of the key players operating in the
  ciclesonide market include AstraZeneca Plc.,
  Cipla Limited, Sun Pharmaceutical Industries
  Ltd., and Apotex Inc.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  insight/buy-now/2291

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

12
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/